# IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation

> **NCT01931865** · PHASE2 · TERMINATED · sponsor: **Yale University** · enrollment: 12 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** IncobotulinumtoxinA

## Key facts

- **NCT ID:** NCT01931865
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-09
- **Primary completion:** 2015-06
- **Final completion:** 2015-07
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** lost the recruiting source- no recruitment for the past 18months, PI moving
- **Last updated:** 2015-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01931865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01931865, "IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01931865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*